Therapeutics and Targets: Identification, Validation, and Markers

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 11-20 of 90 total displayed.

Past content

Reviews
The Transcriptional Corepressor CtBP: A Foe of Multiple Tumor Suppressors

G. Chinnadurai
Cancer Res. 2009; 69: 731-734. [Abstract] [Full text] [PDF]  

Reviews
MicroRNA Silencing in Primates: Towards Development of Novel Therapeutics

Andreas Petri, Morten Lindow, and Sakari Kauppinen
Cancer Res. 2009; 69: 393-395. [Abstract] [Full text] [PDF]  

Subject Review
Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?

Mark Wade and Geoffrey M. Wahl
Mol. Cancer Res. 2009; 7: 1-11. [Abstract] [Full text] [PDF]  

CCR Focus
Triple-Negative Breast Cancer: Risk Factors to Potential Targets

Bryan P. Schneider, Eric P. Winer, William D. Foulkes, Judy Garber, Charles M. Perou, Andrea Richardson, George W. Sledge, and Lisa A. Carey
Clin. Cancer Res. 2008; 14: 8010-8018. [Abstract] [Full text] [PDF]  

Minireviews
Challenge and promise: roles for Livin in progression and therapy of cancer

Ling Wang, Qi Zhang, Bin Liu, Mei Han, and Baoen Shan
Mol. Cancer Ther. 2008; 7: 3661-3669. [Abstract] [Full text] [PDF]  

Reviews
Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway

Toru Akiyama, Crispin R. Dass, and Peter F.M. Choong
Mol. Cancer Ther. 2008; 7: 3461-3469. [Abstract] [Full text] [PDF]  

Reviews
Structural and Functional Basis for Therapeutic Modulation of p53 Signaling

Emily A. Bassett, Wenge Wang, Farzan Rastinejad, and Wafik S. El-Deiry
Clin. Cancer Res. 2008; 14: 6376-6386. [Abstract] [Full text] [PDF]  

CCR Special Focus
The Translational Research Working Group Developmental Pathway for Image-Based Assessment Modalities

Gary S. Dorfman, Daniel C. Sullivan, Mitchell D. Schnall, Lynn M. Matrisian for the Translational Research Working Group
Clin. Cancer Res. 2008; 14: 5678-5684. [Abstract] [Full text] [PDF]  

Review
Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials

Jordi Rodon, Victoria DeSantos, Robert Jean Ferry, Jr., and Razelle Kurzrock
Mol. Cancer Ther. 2008; 7: 2575-2588. [Abstract] [Full text] [PDF]  

Reviews
iASPP Inhibition: Increased Options in Targeting the p53 Family for Cancer Therapy

Helen S. Bell and Kevin M. Ryan
Cancer Res. 2008; 68: 4959-4962. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9